psilocybin

Pharmather company update. Partnership with Queens University Belfast, Ketamine Research, and Microneedle Delivery
PharmaTher Company Update (CSE: PHRM, OTCQB: PHRRF)
Wood Lover's Paralysis Graphic
Wood Lover’s Paralysis: Psilocybin’s Rare Sickness
Decriminalization Bills, DEA Lawsuit: March Roundup
Women in Psychedelic Science Graphic
Drug Science: Women in Psychedelic Science Conference
NYU Langone Center for Psychedelic Medicine
Dr. Michael Bogenschutz of NYU Langone’s Center for Psychedelic Medicine
psilocybin
Denver Psilocybin Panel Talks Expanded Decriminalization
Drug Policy and Decriminalization Graphic
NYC Candidates Talk Decriminalization, NJ Governor “Open-Minded”
Psilocybin and Empathy
Psilocybin, Empathy, and Moral Decision Making
Psychedelics and Coma
Psychedelics, Disorders of Consciousness, and Coma
Breakthrough therapies
Australia Commits $15 Million to Breakthrough Mental Health Therapies but Access Issues Remain